Clinical trial

Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1…

NCT00273988 · Boehringer Ingelheim, Industry · Completed

Key facts

NCT number NCT00273988
Title Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults
Official title A Pharmacokinetic Study to Evaluate the Interaction Between Nevirapine (Viramune®) and Methadone in HIV-1 Infected, Opioid-dependent Adults on Stable Methadone Maintenance Therapy
Lead sponsor Boehringer Ingelheim, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Acquired Immunodeficiency Syndrome
Intervention type Drug
Interventions nevirapine
Enrollment 10
Start date Apr 1, 2002
Primary completion Oct 1, 2003
Completion Oct 1, 2003
First posted Jan 10, 2006
Last update posted Oct 31, 2013
Countries Ireland

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies